Bin Huang

Bin Huang currently works at OncoQuest, Inc., as Chairman.
Dr. Huang also formerly worked at WEX Pharmaceuticals, Inc., as President, CEO & Head-Investor Relations from 2009 to 2013, Cytovax Biotechnologies, Inc., as President & Chief Executive Officer, CK Life Sciences International (Holdings), Inc., as President & Chief Executive Officer, GeneHarbour Technologies, as Chief Executive Officer, Emerald Health Therapeutics, Inc., as President, Chief Executive Officer & Director in 2015, SpeakEasy Cannabis Club Ltd., as Chief Executive Officer & Director from 2019 to 2020, Quest PharmaTech, Inc., as Director from 2015 to 2021, Eternity Healthcare, Inc., as Independent Director from 2013 to 2017, Geyser Brands, Inc., as Director in 2019, GMP Securities LP, as Partner, and Monsanto Canada, Inc., as Vice President-Business Development.
Dr. Huang received her undergraduate degree in 1978 from Wuhan University, Masters Business Admin degree in 1994 from the University of Toronto, and doctorate degree in 1983 from the University of East Anglia.